Viewing StudyNCT00006033



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006033
Status: COMPLETED
Last Update Posted: 2013-05-30
First Post: 2000-07-05

Brief Title: Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
recurrent metastatic squamous neck cancer with occult primary View
stage III squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
recurrent squamous cell carcinoma of the lip and oral cavity View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage III squamous cell carcinoma of the nasopharynx View
stage IV squamous cell carcinoma of the nasopharynx View
recurrent squamous cell carcinoma of the nasopharynx View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
recurrent squamous cell carcinoma of the larynx View
stage III squamous cell carcinoma of the paranasal sinus and nasal cavity View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity View